Kirjallisuus

Aalto A-M & Kangas T (1993) Diabetekseen liittyvät hallintakäsitykset ja terveysuskomukset hoitomuodon ja diabetestyypin mukaan. Sosiaalilääk Aikak 30: 348-360.

Abramson JH (1990) Survey methods in community medicine. Epidemiological studies. Programme evaluation, clinical trials; fourth edition. Longman Singapore Publishers, Singapore.

Agardh C-D, Agardh E & Torffvit O (1997) The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract 35: 113-121.

Agardh D, Gaur LK, Agardh A, Landin-Olsson M, Agardh C-D & Lernmark Å (1996) HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia 39: 1313-1317.

Agardh E, Agardh C-D, Koul S & Torffvit O (1994) A four-year follow-up study on the incidense of diabetic retinopathy in older onset diabetes mellitus. Diabet Med 11:273-278.

Agardh E, Agardh C-D & Hansson-Lundblad (1993) The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 10: 555-559.

Aiello LP, Gardner TW, King GL, Blankenship G, Gavallerano JD, Ferris FL & Klein R (1998) Diabetic retinopathy (Technical review). Diabetes Care 21: 143-156.

Alberti KGMM (1993) Preventing insulin dependent diabetes mellitus. Promising strategies, but formidable hurdles still to clear. Br Med J 307: 1435-1436.

Alberti KGMM & Gries FA (1988) Management of non-insulin-dependent diabetes mellitus in Europe: A concensus view. Diabet Med 5: 275-281.

American College of Physicians & American Diabetes Association, and American Academy of Ophthalmology (1992) Screening guidelines for diabetic retinopathy. Ann Intern Med 116: 683-685.

American Diabetes Association (1998) Diabetic Retinopathy. Position statement. Diabetes Care 21, Supplement 1.

Amiel SA (1993) Diabetic control and complications. Br Med J 307: 881-882.

Amiel SA (1994a) Noninsulin dependent diabetes mellitus. Update 15: 256-263.

Amiel SA (1994b) Insulin-dependent diabetes mellitus. Update 15: 421-428.

Anderson RM, Fitzgerald JT, Wisdom KW, Davis WK & Hiss RG (1997) A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 20: 299-305.

Andersson DKG, Swärdsudd & Tibblin G (1991) Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabet Med 8: 428-434.

Andersson DNK & Svärdsudd K (1995) Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 18: 1534-1543.

Araki A, Ito H, Hattori A, Inoue J, Sato T, Shiraki M & Orimo H (1993) Risk Factors for development of retinopathy in elderly Japanese patients with diabetes mellitus. Diabetes Care 16: 1184-1186.

Arend O, Wolf S, Harris A & Reim M (1995) The relationship of macular microcirculation to visual acuity in diabetic patients. Arch Ophthalmol 113: 610-614.

Arfken CL, Reno PL, Santiago JV & Klein R (1997) Development of proliferative diabetic retinopathy in African-Americans whites with type 1 diabetes. Diabetes Care 21: 792.

Aromaa A, Heliövaara M, Impivaara O et al. (1989) Terveys, toimintakyky ja hoidontarve Suomessa. Kansaneläkelaitoksen julkaisuja AL: 32, Helsinki.

Balkau B, Shipley M, Jarret RJ, Pyörälä K, Pyörälä M, Forhan A, Eshwège E (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21: 360-367.

Bardsley MJ, Astell, McCallum A & Home PD (1993) The performance of three measures of health status in an outpatient diabetes population. Diabet Med 10: 619-626.

Bernbaum M, Albert SG & Duckro PN (1988) Psychosocial profiles in patients with visual impairment due to diabetic retinopathy. Diabetes Care 11: 551-557.

Bingley PJ (1997) Insulin-dependent diabetes: prospects for prevention. Update 24: 347-352.

Blair RD & Kenny LW (1987) Microeconomics with business applications. John Wiley & Sons, New York.

Borch-Johnsen K, Wenzel H, Viberti GC & Mogensen CE (1993) Is screening and intervention for microalbuminuria worthwhile in pateints with insulin dependent diabetes? Br Med J 306: 1722-1723.

Bowling A (1991) Measuring Health. A review of quality of life measurement scales. Open University Press, Milton Keynes, Philadelphia.

Bowman MA (1997) What is cost-effectiveness analysis? Arch Fam Med 6: 527-528.

Brinchmann-Hansen O, Dahl-Jörgensen K, Sandvik L & Hansen KF (1992) Blood glucose consentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. Br Med J 304: 19-22.

Bron AJ & Cheng H (1986) Cataract and retinopathy: Screening for treatable retinopathy. Clin Endocrinol Metab 4: 971-999.

Buxton MJ, Sculpher MJ, Ferguson BA, Humbreys JE, Altman JFB, Spiegelhalter DJ, Kirby AJ, Jacob JS, Bacon H, Dudbridge SB, Stead JW, Feest TG, Cheng H, Franklin SL, Courtney P, Talbot JF, Ahmed R & Dabbs TR (1991) Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med 8: 371-377.

Bäcklund LB, Algvere PV & Rosenqvist U (1997); New blindness in diabetes reduced by more than one-third in Stockholm county. Diabet Med 14: 732-740.

Carey TS, Garrett J, Jackman A, McLaughlin C, Freyer J, Smucker DR & The North Carolina Back Pain Project (1995) The outcomes and costs of care for acute low back pain among patients seen by primary care practitioners, chiropractors, and orthopedic surgeons. N Engl J Med 333: 913-917.

CCOHTA (Canadian Coordinating Office for Health Technology Assessment) (1997) Guidelines for ecomomic evaluation of pharmaceuticals. Canada.

Chan JCN, Cockram CS, Nicholls MG, Cheung CK & Swaminathan R (1992) Comparison of enalapril and nifedipinen in treating non-insulin dependent diabetes associated with hypertension: one year analysis. Br Med J 305: 981-985.

Chantelau E & Kohner EM (1997) Why some cases of retinopathy worsen when diabetic control improves. Worsening retinopathy is not a reason to withholt intensive insulin treatment. Br Med J 315: 1105-1106.

Chase HP, Garg SK, Harris S, Hoops S, Jackson We & Holmes DL (1993) Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two-year trial. Ann Ophthalmol 25: 284-289.

Chaturvedi N, Jarret J, Morrish N, Keen H & Fuller JH (1996) Differences in mortality and morbidity in African Caribbian and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study. Br Med J 313:848-852.

Chaturvedi N, Jarret J, Shipley MJ & Fuller JH (1998a) Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study findings from the Whitehall study and the WHO multinational study of vascular disease in diabetes. Br Med J 316: 100-105.

Chaturvedi N, Sjolie A-K, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepoenik Z, Fuller JH & EUCLID-tutkijaryhmä (1998b) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 351: 28-31.

Chaturvedi N, Stephenson JM & Fuller JH, The EURODIAB IDDM Complications Study Group (1996); The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM complication study. Diabetes Care 19: 423-430.

Chew EY, Klein ML, Ferris FL thrd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ & Miller D (1996) Association of eleveted serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114 (9): 1079-1084.

Chew EY, Klein ML, Murphy RP et al. (1995a) Effects on aspirin on vitrerous/preretinal hemorrhage in patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study Report No. 20. Arch Ophthalmol 113: 52-55.

Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, Conley M, Rand L, Simpson JL, Holmes LB & Aarons JH (1995b) Metabolic Control and Progression of Retinopathy. Diabetes Care 18: 631-637.

Chun BY, Dobson AJ & Heller RF (1997) The impact of diabetes survival among patients with myocardial infarction. Diabetes Care 20: 704-713.

Clark CM & Lee DA (1995) Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 332: 1210-1217.

Cohen DR & Henderson JB (1993) Health Prevention and Economics. Oxford University Press, New York.

Collins VR, Dowse GK, Phlehwe WE, Imo TT, Toelupe PM, Hugh RT & Zimmet PZ (1995) High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 18: 1140-1149.

Constable IJ, Wellborn TA, Cooper RL, McCann VJ, Standon KM Greer DV, Stein G & Sebastian P (1980) Symposium on medical ophthalmology. Medical correlates and diabetic retinopathy screening. Trans Ophthalmol Soc UK 100: 78-82.

Cox DR &Oakes D (1984) Analysis of survival data. Chapman et Hall, New York.

Crepaldi G & Manzato E (1988) Atherogenic factors in diabetes: the role of lipoprotein metabolism. Postgrad Med J 64: (suppl 3) 10-12.

Croxon B (1998) From private club to professional network: An economic history of the health economists’ study group, 19972-1997. Health Econ 7: S 9-S45

Dasbach EJ, Fryback DG, Newcomb PA, Klein R & Klein BEK (1991) Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 29: 20-39.

Dasbach EJ, Klein R, Klein BEK & Moss SE (1993) Self-rated health and mortality in people with diabetes. Am J Public Health 84: 1775-1779.

Davis MD (1992) Diabetic retinopathy. A clinical overview. Diabetes Care 15: 1844-1874.

Davis MD, Hiller R, Magli YL, Podgor MJ, Ederer F, Harris WA, Long JW, Haug GA (1979) Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc 77: 144-170

Davis MD, Hubbard LD, Trautman J & Klein R for the Collaborative Study Group (1985) Studies of retinopathy. Methodology for assessment and classification with fundus photographs. Diabetes 34: 42-49.

Davis MD & Rand LI (1992) Diabetic retinopathy. Alberti KGMM, Defronzo RA, Keen H, Zimmet P (eds) International Textbook of Diabetes Mellitus 2: 1329-1372. Halden Press, Oxford.

Deckert T, Simonson SvE & Poulsen JE (1967) Prognosis of proliferative retinopathy in juvenile diabetics. Diabetes 16: 727-733.

Deckert T, Yokoyama H, Mathiesen E, Rønn B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K & Skov Jensen J (1996) Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. Br Med J 312: 871-874.

DEKODE Study Group on behalf of the European Diabetes Epidemiology Study Group (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. Br Med J 317: 371-375.

The Diabetes Control and Complications Trial Research Group (1988) Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complication trial (DCCT). Diabetes Care 11: 725-732.

The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.

The Diabetes Control and Complications Trial Reseach Group (1995) The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial. Diabetes 44: 968-983.

The Diabetic Retinopathy Study Research Group (1978) Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings. Ophthalmology 85: 82-106.

The Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy, Clinical applications of diabetic retinopathy study (DRS) findings, DRS report number 8. Ophthalmology l 88: 583-600.

Diabetes Integrated Care Evaluation Team (1994) Integrated care for diabetes: clinical, psychosocial, and economic evaluation. Br Med J 308: 1208-1212.

Dickson PR, McCarthy CA, Keeffe JE, Baxter R, Harper CA & Taylor HR (1996). Diabetic retinopathy: examination practices and referral patterns of general practitioner. Med J Aust 164: 341-344.

Diglas J, Willinger C, Neu U & Irsigler K (1992); Morbidität und Letalität bei Typ-I- und Typ-II-Diabetikern nach Diagnose einer diabetischen Retinopathie. Dtsch Med Wochenschr 117: 1703-1708.

Dodson PM & Gibson JM (1991) Long term follow-up of and underlying medical conditions in patients with diabetic exudative maculopathy. Eye 5: 699-703.

Doessel DP (1987) Health outcome and higher medical qualifications: an economic conception and notes on implementation. Soc Sci Med 24: 897-910.

Dolan P, Gudex C, Kind P & Williams A (1996) The time trade-off method: Results from a general population study. Health Econ 5: 141-154.

Donaldson C, Shackley P, Abdalla M & Miedzybrodzka Z (1995) Willingness to pay for antenatal carrier screening for cystic fibrosis. Health Econ 4: 439-452.

Dorf A, Ballantine EJ, Bennet PH & Miller M (1976) Retinopathy in Pima Indians. Relationship to glucose level, duration of diabetes, age at diagnosis of diabetes, and age at examination in a population with a high prevalence of diabetes mellitus. Diabetes 27: 554-560.

Dornan TL, Peck GM, Dow JDC & Tattarsall RB (1992) A community survey of diabetes in elderly. Diabet Med 9: 860-865.

Dowse G, Zimmet P & Alberti KGMM (1992); Screening for diabetes and other categories of glucose intolerance. Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (Eds) International Textbook of Diabetes Mellitus 2: 1565-1587. Halden Press, Oxford.

Drummond MF (1990) Allocating resources. Int J Technol Assess Health Care 6: 77-92.

Drummond M (1995) Economic analysis alongside clinical trials: problems and potentials. J Rheumatol 22: 1403-1407.

Drummond MF, Davies LM & Ferris III FL (1992) Assessing the costs and benefits of medical research: The diabetic retinopathy study. Soc Sci Med 34: 973-981.

Drummond M & O’Brien B (1993) Clinical importance, statistical significance and the assessment of economic quality-of-life outcomes. Health Econ 2: 205-212.

Drummond M & O’Brien B (1995) Economic analysis alongside clinical trials: practical considerations. J Rheumatol 22: 1418-1419.

Drummond MF, O’Brien B, Stoddart GL & Torrance GW (1997) Methods for the economic evaluation of health care programmes, second edition. Oxford University Press, Oxford.

Drummond MF, Stoddart GL & Torrance GW (1987) Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford.

Dunn SM (1990) Rethinking the models and modes of diabetes education. Patient Educ Couns 16: 281-286.

Dwyer MS, Melton LJ, Ballard DJ, Palumbo PJ, Trautmann JC & Chu C-P (1985) Incidence of diabetic retinopathy and blindness: A population-based study in Rochester, Minnesota. Diabetes Care 8: 316-322.

Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 1. Arch Ophthalmol 103: 1796-1806.

Eggertsen R, Kalm H & Blohme G (1993) The value of screening for retinopathy and microalbuminuria in patients with type 2 diabetes in primary health care. Scand J Prim Health Care 11: 135-140.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197.

Falck A (1996) Occurrence, natural history and risk factors of retinopathy in diabetic children and adolescents. Acta Univ Oul D 368.

Falck A, Käär M-L, Laatikainen L (1996) A prospective longitudinal study examining the development of retinopathy in children with diabetes. Acta Paediatr 85: 313-319.

Ferris FL III (1993) How effective are treatments for diabetic retinopathy. JAMA 269: 1290-1291.

Ferris FL III (1994) Results of 20 years research on the treatment of diabetic retinopathy. Prev Med 23: 740-742.

Ferris FL III (1996) Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc 94: 505-537.

Le Floch JP, Charles MA, Philippon C & Perlemuter L (1994) Cost-effectiveness of screening for microalbuminuria using immunochemical dipstic tests or laboratory assays in diabetic patients. Diabet Med 11: 349-356.

Forsblom C & Ekstrand A (1997) Mikroalbuminuri och insulinresistens: samband med diabetisk nefropati och kardivaskulär sjukdom. Finska Läkaresällsk Handl 157: 38-42.

Foulds WS, McCuish A, Barrie T, Green F, Scobie IN, Ghafour IM, McClure E & Barber JH (1983) Diabetic retinopathy in the West of Scotland: Its detection and prevalence, and the cost-effectiveness of a proposed screening programme. Health Bull 41: 318-326.

Gabriel SE (1995) Economic evaluation using mathematical models: The case of misoprostol prophylaxis. J Rheumatol 22: 1412-1414.

Gafni A & Torrance GW (1984) Risk attitude and time preference in health. Manage Sci 30: 440-451.

Gatling W, Howie AJ & Hill RD (1995) An optical practice based diabetic eye screening programme. Diabet Med 12: 531-536.

Gaudric A & Massin-Korobelnik P (1993) Maculopathie diabétique: classification, épidémiologie, évolution spontanée, traitement. Diabete & Metabolisme 19: 422-449.

Gerard K & Mooney G (1993) QALY league tables: handle with care. Health Econ 2: 59-64.

Giansanti R, Boemi M, Amodio L, Fioravanti P, Rabini RA & Fumelli P (1994) Long-term metabolic control and retinopathy in type I diabetes: Ten-year follow-up. Diabetes Research 25: 77-84.

Gibbins RL, Owens DR, Allen JC & Eastman L (1998) Practical application of the European Field Guid in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides. Diabetologia 41:59-64.

Gilks WR, Richardson S & Spielhalter DJ (1996) Marcov chain Monte Carlo in practice. Chapman & Hall, London.

Gilmer TP, O’Connor PJ, Manning WG & Rush WA (1997) The cost to health plans of poor glycemic control. Diabetes Care 20: 1847-1853.

Gold MR, Siegel JE, Russell Lb & Weinstein MC ed (1996); Cost-effectiveness in health and medicine. Oxford Universitys Press, New York.

Greenfield S, Kaplan SH, Ware JE, Yano EM & Frank HJJ (1988) Patients’ participation in medical care: Effects on blood sugar control and quality of life in diabetes. J Gen Intern Med 3: 348-57.

Greenwood RH (1996) Population-based screening for diabetic retinopathy: a promising start. Diabet Med 13: 925-926.

Griffin S (1998) Diabetes care in general practice: meta-analysis of randomised control trials. Br Med J 317: 390-396.

Griffith LS, Field BJ & Lustman PJ (1990) Life stress and social support in diabetes: Association with glycemic control. Int J Psychiatry Med 20: 365-372.

Güven D, Özdemir H & Hasanreisoglu B (1996) Hemodynamic alterations in diabetic retinopathy. Ophthalmology 103: 1245-1249.

Hahl J, Simell R, Ilonen J, Knip M Simell O (1998) Costs of predicting IDDM. Diabetologia 41: 79-85

Ham C (1993) Priority setting in the NHS: reports from six districts. Br Med J 307: 435-438.

Harding SP, Broadbent DM, Neoh C, White M & Vora J (1995) Sensitivity and specificity of photography and direct ophtalmoscopy in screening for sight threatening eye diseases: the Liverpool diabetic eye study. Br Med J 311: 1131-1135.

Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD ( 1998) Is the risk of diabetic retinopathy greater in non-Hispanic blacs and Mexican Americans than in non-Hispanic whites with type 2 diabetes? Diabetes Care 21: 1230-1235

Harrison RJ, Wild JM & Hobley AJ (1988) Referral patterns to an ophthalmic outpatient clinic by general practitioners and ophthalmic opticians and the role of these professionals in screening for ocular disease. Br Med J 297: 1162-1167.

Harvey CM (1994) The reasonableness of non-constant discounting. J Public Econ 53: 31-51

Haukipuro K & Niemi V (1981) Ylipaino keskeinen ongelma diabeteksen hoidossa. Suom Lääkäril 36: 428-430.

Helbig H, Kellner U, Bornfeld N & Foerster MH (1996) Life expectancy of diabetic patients undergoing vitreous surgery. Br J Ophthalmol 80: 640-643.

Hellstedt T, Ikonen P, Weman S & Summanen P (1998) Valoa diabeettisen retinopatian varhaisvaiheisiin. Duodecim 114: 295-302.

Henricsson M & Heijl A (1994a); Visual fields at different stages of diabetic retinopathy. Acta Ophthalmol 72: 560-569.

Henricsson M & Heijl A (1994b) The effect of panretinal laser photocoagulation on vilual aquity, visual fields an on subjective visual impairment in preproliferative and early proliferative diabetic retinopathy. Acta Ophthalmol 72: 570-575.

Henricsson M, Janzon L & Groop L (1995) Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM. Diabetes Care 18: 1571-1576.

Henricsson M, Nilsson A, Janzon L & Groop L (1996) The effect of glycemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med 14: 123-131.

Henricsson A, Nilsson A, Janzon L & Groop L (1997) The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med 14: 123-131.

Henricsson M, Tyrberg M & Heijl A (1996) Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening rogramme. Acta Ophthalmol Scand: 533-538.

Hiltunen L (1997) Diabetes mellitus and impaired glucose tolerance in northern Finnish elderly subjects. Acta Univ Oul D 437.

Hiltunen L, Keinänen-Kiukaanniemi S, Läärä E & Kivelä S-L (1996) Functional ability of elderly persons with diabetes or impaired glucose tolerance. Scand J Prim Health Care 14: 229-237.

Hiltunen L, Luukinen H, Koski K & Kivelä S-L (1995). Prevalence of diabetes mellitus in an elderly Finnish population. Diabet Med 11: 241-249.

Hirvelä H (1995). Visual function and ocular disease in the elderly. Acta Univ Oul D 327.

Holland WW (1993) Screening: reasons to be cautious. Br Med J 306: 1222-1223.

Hollingworth W, Todd C, Parker M, Roberts JA & Williams R (1993) Cost analysis of early discharge after hip fracture. Br Med J 306: 903-906.

Howitt A & Cheales NA (1993) Diabetes registers: a grassroots approach. Br Med J 307: 1046-1048.

Huhtakangas J, Miettinen R & Laatikainen L (1992) Diabeettisen retinopatian seulonta valokuvauksen avulla terveyskeskuksessa. Suom Lääkäril 47: 3316-3320.

Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J & Papp E (1980) A quantitative approach to perceived health status: a validitation study. J Epidemiol Community Health 34: 281-286.

Hunt SM, McKenna SP & Williams J (1981) Reliability of a population survey tool for measuring perceived health problems: a study of patients with osteoarthrosis. J Epidemiol Community Health 35: 297-300.

Häkkinen U (1992). Terveyspalvelujen käyttö, terveydentila ja sosioekonominen tasa-arvo Suomessa. Sosiaali- ja terveyshallitus, tutkimuksia 20.

Häyry M (1997) Oikeudenmukaisuuden hyödyllisyys terveydenhuollossa - Humen periaatteesta Oregon ratkaisuun. Sosiaalilääk Aikak 34: 47-59.

Jackson WE, Holmes DL, Garg SK, Harris S & Chase HP (1992) Angiotensin-converting enzyme inhibitor therapy and diabetic retinopathy. Ann Ophthalmol 24: 99-103.

Jacob J, Stead J, Sykes J, Taylor D & Tooke JE (1995) A report on the use of technician ophthalmoscopy combined with the use of the Canon non-mydriatic camera in screening for diabetic retinopathy in the community. Diabet Med 12: 419-425.

Jacobs P & Baladi J_F (1996) Biases in cost measurements for economic evaluation studies in health care. Health Econ 5: 525-529.

Jacobson AM, Rand LI & Hauser ST (1985) Psychologic stress and glycemic control: A comparison of patients with and without proliferative diabetic retinopathy. Psychosom Med 47: 372-380.

Jarret RJ (1989) Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol Rev 11: 151-171.

Jarret RJ & Shipley MJ (1985) Mortality and associated risk factors in diabetics. Acta Endocrinol 119 Suppl 272: 21-26..

Javitt JC & Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124: 164-169.

Javitt JC, Aiello LP, Chiang Y, Ferris FL thrd, Canner JK &Greenfield S (1994) Preventive eye care in people with diabetes is cost-saving to the federal government. Diabetes Care 17: 909-917

Javitt JC, Canner JK, Frank RG, Steinwachs DM & Sommer A (1990) Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model. Ophthalmology 97:483-494.

Jerneld B (1988) Prevalence of diabetic retinopathy . A population study from the Swedish island of Gotland. Acta Ophthalmol 66, suppl 188.

Joannou J, Kalk WJ, Mahomed I, Ntsepo S, Joffe BI, Raal FJ, Sachs E, van der Merve MT & Wing JR (1996) Screening for diabetic retinopathy in South Africa with 60˚ retinal colour photography. J Intern Med 239: 43-47.

Kaivonen M & Lavikainen P (1983) Diabeettisen retinopatian esiintyminen ja hoidon tarve. Suom Lääkäril 38: 1035-1041.

Kalm H (1993) Diabetic retinopathy screening, Method et strategy, Göteborg.

Kangas T (1993) Diabeetikoiden hoito Suomessa. Avohoito, sairaalahoito ja hoitotasapaino. STAKES, Tutkimuksia 29.

Kangas T, Reunanen A, Koivisto VA, Salinto M, Kosonen K, Valkama N & Aro S (1995) Direct costs of health care of drug-treated patients in Finland in 1989. Helsinki: Stakes Research Reports 58: 153-163.

Kansaneläkelaitoksen tilastollinen vuosikirja 1994 (1995) Kansaneläkelaitos, Vammala.

Kansaneläkelaitos (1996) Terveyspalveluiden kustannukset ja rahoitus Suomessa 1960-94. Kansaneläkelaitoksen julkaisuja T9: 52, Helsinki.

Karma A (1989) Silmänpohjalöydösten tulkitseminen yleislääkärin vastaanotolla. Vox 11: 43-55.

Karma A (1994) Miten tutkin silmänpohjat? Diabetes ja lääkäri, kesäkuu: 22-3.

Karma A, Gummerus S, Kujansuu E, Murto S, Karinkanta H & Pitkäjärvi T (1986b) Diabeettisen verkkokalvosairauden ennustettavuus. Duodecim 102: 1575-1585.

Karma A, Gummerus S & Pitkäjärvi T (1986a) Diabeetikon silmänpohjaseulonta terveyskeskuksessa. Suom Lääkäril 41:16-20.

Karvonen M, Tuomilehto J, Libman I & LaPorte R for the World Health Organisation DIAMOND Project Group (1993) A review of the recent epidemiological data on the worldwide incidence of Type 1(insulin dependent) diabetes mellitus. Diabetologia 36: 883-892.

Kaplan RM, Hartwell SL, Wilson DK & Wallace JP (1987) Effects of diet and exercise interventions on control and quality of life in non-insuin-dependent diabetes mellitus. J Gen Intern Med 2: 220-227.

Kauppi S (1997) Toimintoperusteinen laskenta sairaalan tulosyksikössä. Pro gradu –tutkielma. Oulun yliopisto, taloustieteen laitos.

Kawagishi T, Nishizawa Y, Emoto M, Konishi T, Maekawa K, Hagiwara S, Okuno Y, Inada H, Isshiki G & Morii H (1995) Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy. Diabetes Care 18: 1544-1549.

Keen H (1998) Impact of new criteria for diabetes on pattern of disease. Lancet 352: 1000-1001

Keiding N, Holst C & Green A (1989) Retrospective estimation of diabetic incidence from information in a prevalent population and historical mortality. Am J Epidemiol 130: 588-600.

Keinänen-Kiukaanniemi S & Niemi M (1994). Detection of retinopathy by non-mydriatic fundus photography in diabetics treated with oral hypoglycaemic agents or diet. Scand J Prim Health Care12: 32-38.

Keinänen-Kiukaanniemi S, Ohinmaa A & Koivukangas P (1994) Aikuisdiabeetikkojen elämänlaatu NHP-mittarilla mitattuna. Sosiaalilääk Aikak 31: 70-76.

Keinänen-Kiukaanniemi S, Ohinmaa A, Pajunpää H & Koivukangas P (1996) Health related quality of life in diabetic patients measured by the Nottingham Health Profile. Diabet Med 13: 382-388.

Kiberd BA & Jindal KK (1995) Screening renal failure in insulin dependent diabetic patients: an economic evaluation. Br Med J 311 1595-1599.

Kinmon A-L (1993) Diabetic care in general practice, Adding quality to quantity. Br Med J 306: 599-600.

Klein BEK & Klein R (1990) Ocular problems in older Americans with diabetes. Clin Geriatr Med 6: 827-837.

Klein BEK, Klein R, Moss SE & Palta M (1995d) A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch ophthalmol 113: 601-606.

Klein BEK, Klein R & Moss SE (1998) Self-related health and diabetes of long duration. Diabetes Care 21: 236.

Klein R (1995a) Prevention of visual loss associated with diabetes mellitus: An Epidemiologic Perspective. Focus on Diabetic Retinopathy 2:72-79.

Klein R (1995b) Hyperclycemia and microvascular disease in diabetes. Diabetes Care 18: 258-268.

Klein R, Klein BEK & Lee KE (1996) Changes in visual acuity in a population, The Beaver Dam Eye Study. Ophthalmology 103: 1169-1178.

Klein R, Klein BEK & Moss SE (1990) The Wisconsin epidemiologic study of retinopthy: An update. Aust N Z J Ophthalmol 18: 19-22.

Klein R, Klein BEK & Moss SE (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15: 1875-1891.

Klein R, Klein BEK & Moss SE (1995c) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113: 333-339.

Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984a) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526

Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984b) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532.

Klein R, Klein BEK, Moss SE & Wang Q (1994) Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol 112: 92-98.

Klein R & Moss SE; Visual impairment and diabetes (1992) Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (Eds) International Textbook of Diabetes Mellitus 2: 1373-1384, Halden Press, Oxford.

Klemetti A & Karma A (1986) Diabeettisen retinopatian seuranta ja hoito. Duodecim 10: 1293-1300.

Kohner EM (1993) Diabetic retinopathy. Br Med J 307: 1195-1199.

Kohner E, Allwinkle J, Andrews J, Baker R, Brown F, Cheng H, Gray M, Grindley S, Koppel I, Martin B, Reckles J, Rothman D, Sculpher M, Talbot F & Vaughan J (1996) Report of the visual handicap group. Diabet Med 13: S 13-26.

Kohner EM & Oakley NW (1975) Diabetic retinopathy. Metabolism 24: 1085-1102.

Kohner EM & Porta M (1992) Screening for diabetic retinopathy in Europe: A field guide-book. Presso le Industrie Grafiche della Pacini Editore, Pisa.

Koivisto V (1990) Diabeteksen hoitotasapaino ja komplikaatiot. Duodecim 106: 643-646.

Koivisto V, Knip M, Nikkanen P, Saltevo J, Vähätalo M & Heinonen L (1995) Nuoruustyypin diabeteksen hoitosuositus. Suomen Diabetesliitto ry:n julkaisusarja 1.

Koivisto V & Uusitupa M (1997) Diabeteksen lääkehoito, Kapseli 26, Lääkelaitos, Kansaneläkelaitos.

Koivukangas P (1993) A two-wave mimic model for the construction of a health status index based on the health production function, with special reference to the assessment of neurosurgical treatment of brain tumour patients. Acta Univ Oul C 69, Oulu.

Koivukangas P, Koivukangas J, Ohinmaa A, Kivelä S-L & Krause K (1992) NHP - Koetun terveydentilan mittari terveydenhuollon arviointitutkimuksiin. Sosiaalilääk Aikak 29: 229-235.

Koivukangas P, Ohinmaa A & Koivukangas J (1995) Nottingham Health Profilen (NHP) suomalainen versio. Stakes, Raportteja 187.

Koivukangas P & Syrjälä H (1994) Sairaalainfektioiden ehkäisyn kustannusten ja hyötyjen arvionti. Suomen Kuntaliitto, Infektioiden torjunta sairaalassa, Helsinki.

Kokkonen J, Laatikainen L, v.Dickhoff K, Miettinen R, Tuominen M, Lautala P & Salmela P (1993) Tyypin 1 diabetekseen liittyvät silmäkomplikaatiot. Duodecim 109: 1923-1928.

Komiteamietintö 5 (1976) Suunnitelma sokeritaudin hoidon järjestämiseksi Suomessa. Valtion painatuskeskus, Helsinki.

Koopmanschap MA & Rutten FF (1996) A practical guide for calculating indirect costs of disease. PharmacoEconomics 4: 460-666.

Koskinen VP, Martelin TP & Valkonen T (1996) Socioeconomic differences in mortality among diabetic people in Finland: five year follow up. Br Med J, 313: 975-978.

Kosonen K & Valkama N (1993) Diabeteksen yhteiskunnalliset kustannukset Suomessa 1989; Opinnäytetutkielma, Kuopion yliopisto, Yhteiskuntatieteellinen tiedekunta, Terveyshallinnon ja -talouden laitos.

Kovacs M, Mukerji P, Drash A, Iyenger S (1995) Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 18: 1592-1599

Kraft SK, Marrero DG, Lazaridis EN, Fineberg N Qiu D & Clark CM Jr (1997) Primary care physicians’ patterns and diabetic retinopathy, current levels of care. Arch Fam Med 6: 29-37.

Krahn M & Gafni A (1993) Discounting in theeconomic evaluation of health care interventions; Med Care 31: 403-418.

Krop JS, Powe NR, Weller WE, Shaffer TJ, Saudek CD & Anderson GF (1998) Patterns of expenditures and use of services among older adults with diabetes. Diabetes Care 21: 747.

Kristensson JK, Gudmunsson JR, Stefánsson E, Jónasson F, Gíslason I & Thórsson AV (1995) Screening for diabetic retinopathy. Acta Ophthalmol Scand 73: 525-528.

Kristensson JK, Hauksdóttir H, Stefánsson E, Jónasson F& Gislason I (1997) Active prevention in diabetic eye disease: A 4-year follow-up. Acta Ophthalmol Scand 75: 249-254.

Kuiv R, Tein P, Algvre V, Backlun LB & Holm O (1997) Photographic detection of retinopathy in insulin-treated diabetes. Acta Ophthalmol Scand 75: 447-456

Kullberg CE & Arnquist HJ (1993) Elevated long-term glycated haemoglobulin precedes proliferative retinopathy and nephropathy in type 1 (indulin-dependent) diabetes patients. Diabetologia 23: 961-965.

Kunnallinen työmarkkinalaitos (1992) Kunnallinen yleinen virka- ja työehtosopimus 1992-1993, Helsinki.

Kuotola U (1976) Näkövammaisten integroituminen yhteiskuntaan. Acta Univ Tamp A 82, Tampereen yliopisto, Tampere.

Laakso M, Reunanen A, Klaukka T, Aromaa A, Maatela J & Pyörälä K (1991) Changing the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-87. Am J Epidemiol 133: 850-857.

Laatikainen L (1981) & Diabeteksen silmäkomplikaatiot. Duodecim 97: 898-907.

Lairson DR, Pugh JA, Kapadia AS, Lorimor RJ, Jacobson J & Velez R (1992) Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care 15: 1369-1377.

Lasker RD (1993) The Diabetes Control and Complications Trial, Implications for policy and practice. N Engl J Med 329: 1035-1036.

Lee ET, Howard BV, Savage PJ, Fabitz RR, Oopik AJ, Yeh J, Go O, Robbins DC & Welty TK (1995) Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. Diabetes Care 18: 599-610.

Lee VS, Kingsley RM, Lee ET, Lu M, Russell D, Asal NA, Bradford RH & Wilkinson CP (1993) The diagnosis of diabetic retinopathy, Ophthalmoscopy versus fundus photography. Ophthalmology 100: 1504-1512.

Lee ET, Lee VS, Lu M & Russel D (1992) Development of proliferative retinopathy in NIDDM, A follow-up study of American indians in Oklahoma. Diabetes 41: 359-367.

Leese B (1992) The costs of diabetes and its complications. Soc Sci Med 35: 1303-1310.

Leese GP, Broadbent DM, Harding SP & Vora JP (1996) Detection of sight-threatening diabetic eye disease. Diabet Med 13: 850-853.

Lewis EJ, Hunsicker LG, Bain RP & Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462.

Lionis CD, Sasarolis SM, Koutis AD, Antonikis NA, Benos A, Papavsiliou S & Fioretos M (1996) Measuring the prevalence of diabetes mellitus in a Creek primary health care district. Fam Pract 13: 18-21.

Lipscomb J (1989) Time preference for the health in cost-effectiveness analysis. Med Care 27 (Suppl): S223-S253.

Luce BR & Elixhauser A (1990); Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 6: 57-75.

Mandarino LJ (1992) Current hypothesis for the biochemical basis of diabetic retinopathy. Diabetes Care 15: 1892-1901.

Manninen DL & Evans RW (1988) A longitudinal assessment of the health status of diabetic and non-diabetic renal transplant recipients. Clin Transpl 203-209.

Mason J & Drummond M (1995) Screening for diabetic retinopathy by optometrics: effectiveness and cost-effectiveness. Discussion paper 137, Centre of Health Economics, University of York.

Matsushima M, Shimizu K, Maryama M, Nishimura R, LaPorte RE & Tajima N for the Diabetes Epidemiology Research International (DERI) (1996) US-Japan Mortality study group. Diabetologia 39: 710-716.

Matz H, Falk M, Göttiger W & Kieselbach G (1996) Cost-benefit analysis of diabetic eye disease. Ophthalmologica 210: 348-253.

Mayou R, Bryant B & Turner R (1990) Quality of life in non-insulin-dependent diabetes and a comparison with insulin-dependent diabetes. J Psychosom Res 34: 1-11

Merimee TJ (1990) Diabetic retinopathy, a synthesis of perspectives. N Engl J Med 322: 978-983.

Meyer-Schwickerath G (1959) Lichtkoagulation. Bucherai des Augenarztes, Beihefte Klin Monatsbl Augenheilk Heft 33, Enke Verlag, Stuttgart.

MGuire A, Henderson J & Mooney G (1988) The economics of health care, An introductory test. Routledge & Kegan Paul.

McLelland (1990) Low-cost Mass Screening as a means of reducing overall mortality from breast cancer. Recent Results Cancer Res 119: 54-59.

Michaelis D, Jutzi E & Albrect G (1987) Prevalence and incidence trends of non-insulin-dependent diabetes mellitus (NIDDM) in the population of the GDR. Dtsch Z Verdau.-Stoffwechs Krankh 47: 301-310.

Mishan EJ (1988) Cost-benefit analysis, an informal introduction, 4th ed. Unvin Hyman.

Mitchell P (1985) Development and progression of diabetic eye disease in Newcastle (1977-1984): Rates and risk factors. Aust N Z J Ophthalmol 13: 39-40.

Mitchell P & Moffitt P (1990) Update and implivcations from the Newcastle diabetic retinopathy study. Aust N Z J Ophthalmol 18: 13-7.

Mitchell RC & Carson RT (1989); Using surveys to value public goods: the contingent valuation method. Washington DC: Resources for the Future.

Mooney G (1992) Economics, Medicine and Health Care, Harvester.

Morrison GC & Gyldmark M (1992) Appraising the use of contingent valuation. Health Econ 1: 233-243.

Moss SE, Klein R & Klein BEK (1988) The incidence of vision loss in a diabetic population. Ophthalmology 95; 1340-1348.

Moss SE, Klein R & Klein BEK (1990) The validity of estimating the incidence of diabetic retinopathy from prevalence. Am J Epidemiol 131: 644-651.

Moss SE, Klein R & Klein BEK (1994) Ten-year incidence of visual loss in a diabetic population. Ophthalmology 100:1061-1070.

Mykkänen L & Niskanen L (1990) Aikuisiän diabeteksen ennuste. Duodecim 106: 725-730.

Mäkelä H (1992) Kustannus-hyöty- ja kustannus-vaikuttavuusanalyysi terveydenhuollon teknologian arviointitutkimuksessa.. Pro gradu –tutkielma. Oulun yliopisto, taloustieteen osasto.

Mäkelä J (1996) Diabeettisen retinopatian seulonta ja seuranta valokuvauksen avulla terveyskeskuksessa. Kunnallislääkäri 3/1996: 19-22

Mäntyjärvi M, Nissinen A, Uusitupa M & Enlund H (1993) Diabeetikkojen säännölliset silmätarkastukset perusterveydenhuollossa. Suom Lääkäril 48: 1365-1369.

Nabarro JDN (1991) Diabetes in the United Kingdom: a personal series. Diabet Med 8: 59-68.

Nagi DK, Pettitt DJ, Bennett PH, Klein R & Knowler WC (1997) Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabet Med 69:335-338.

Nathan DM (1995) Inferences and implications: Do results from the Diabetes Control and Complications Trial apply in NIDDM? Diabetes Care 18: 251-257.

Newcomb PA, Klein R & Massoth KM (1992) Education to increase ophthalmologic care in older onset diabetes patients: Indications from the Wisconsin epidemiologic study of diabetic retinopathy. J Diabetes Complications 6: 211-217.

Nielsen NV (1984a) Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The island of Falster, Denmark. Acta Ophthalmol 62: 256-265.

Nielsen NV (1984b) Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycamic agents and diet regime alone. A one year epidemiological cohort study of diabetes mellitus. The island of Falster, Denmark. Acta Ophthalmol 62: 266-673.

Niemi M (1989) Retinopatian esiintyvyys ja riskitekijät tabletti- ja ruokavaliohoitoisilla diabeetikoilla. Kansaneläkelaitoksen julkaisuja, Turku.

Noller KL (1996) Screeening for vaginal cancer. N Engl J Med 335:1559-1560.

Noro A, Aro S (1996) Health-related quality of life among the least dependent institutional elderly compared with the non-institutional elderly population. Qual Life Res 5: 355-366

North RV, Farrel U, Jones C, Gregory JW & Owens DR (1997) Visual function in young ISSM patients over 8 years of age. A 4-year longitudinal study. Diabetes Care 20: 1724-1730.

Näkövammarekisterin vuosikirja 1992 (1993) Sosiaali- ja terveysalan tutkimus- ja kehittämiskeskus, Näkövammaisten Keskusliitto ry, Helsinki.

Näkövammarekisterin vuosikirja 1993 (1994) Sosiaali- ja terveysalan tutkimus- ja kehittämiskeskus, Näkövammaisten Keskusliitto ry, Helsinki.

Näkövammarekisterin vuosikirja 1994 (1995) Sosiaali- ja terveysalan tutkimus- ja kehittämiskeskus, Näkövammaisten Keskusliitto ry, Helsinki.

Näkövammarekisterin vuosikirja 1995 (1996) Sosiaali- ja terveysalan tutkimus- ja kehittämiskeskus, Näkövammaisten Keskusliitto ry, Helsinki.

Näkövammarekisterin vuosikirja 1996 (1997) Sosiaali- ja terveysalan tutkimus- ja kehittämiskeskus, Näkövammaisten Keskusliitto ry, Helsinki.

Näkövammarekisterin vuosikirja 1997 (1998) Sosiaali- ja terveysalan tutkimus- ja kehittämiskeskus, Näkövammaisten Keskusliitto ry, Helsinki.

Nørgaard K, Feldt-Rasmussen B & Deckert T (1991) Is hypertension a major independent risk factor for retinopathy in type 1 diabetes? Diabet Med 8:334-337.

O’Brien B (1995) Principles of economic evaluation for health care programs. J Rheumatol 22: 1399-1402.

O’Brien JA, Shomphe LA, Kawanagh PL, Raggio G, Caro JJ (1998) Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 21: 1122-1128

O’Connor PJ (1991) Diabetes Care: What should we try to achieve? J Fam Pract 33: 343-344.

Ohinmaa A, Niemelä A, Koivukangas P & Koivukangas J (1993) Terveyteen liittyvän elämänlaadun mittaaminen aivokasvainpotilailla. Sosiaalilääk Aikak 30: 203-10

Ojamo M (1995) Sosiaalioftalmologiaa. Miten näkövammaan liittyvät tekijät vaikuttavat henkilön työllistymiseen. Näkövammarekisterin vuosikirja 1994: 105-111

Ojamo M (1996) Rekisteröityjen näkövammaisten sosiaalinen asema. Näkövammarekisteri, Sosiaali- ja terveysalan kehittämiskeskus (STAKES), Näkövammaisten Keskusliitto, Näkövammaisten Keskusliiton julkaisuja 1/1996

Olsen C, Kassoff A & Gerber T (1989) The care of diabetic patients by ophtahlmologists in New York State. Ophthalmology 96:439-445.

Oulun yliopistollisen sairaalan palveluhinnasto vuodelle 1994.

Owens DR, Dolben J, Young S, Ryder REJ, Jones IR, Vora J, Jones D, Morsman D & Hayes TM (1991) Screening for diabetic retinopathy. Diabet Med 8 Symposium: S4-S10.

Owens DR, Gibbins RL, Lewis PA, Wall S, Allen JC & Morton R (1998) Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography asa 35 mm colour transparencies? Diabet Med 15: 170-175.

Pakkanen J, Tuomilehto J, Uutela A, Vartiainen E & Nissinen A (1995) Social class, health behaviour, an mortality among men and women in eastern Finland. Br Med J 311: 989-993.

Parrsih RK II (1996) Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Am Ophthalmol Soc 94: 919-1023.

Parving H-H (1991) Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, an endothelial permeability in diabetes mellitus. Diabetes Care 14: 260-269.

Pekurinen M (1994) Kuntoutuksen taloudellisen arvioinnin menetelmä Duodecim 110: 1458-1467.

Peters AL, Davidson M & Ziel FH (1993) Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting. Diabetes Care 16:1193-1195.

Phelps CE (1993) The methodolic foundations of studies of the appropriateness of medical care. N Engl J Med 329: 1241-1245.

Polak BCP (1995) Current research in diabetic retinopathy: A Review. Focus on Diabetic Retinopathy 2: 80-83.

Porta M, Tomalino MG, Santoro F, Ghigo LD, Cairo M, Aimone M, Pietragalla GB, Passera P, Montanaro M & Molinatti GM (1995) Diabetic retinopathy as a cause of blindness in the province of Turin, North-west Italy, in 1967-1991. Diabet Med 12: 355-361.

Portney PR (1994) The contingent valuation debate: why economics should care. J Econ Perspect 8: 3-17.

Pyörälä K, Laakso M & Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3: 463-524.

Qiao Q, Keinänen-Kiukaanniemi S & Läärä E (1997) The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol 50: 153-158.

Rahmani B, Tielsch JM, Katz J, Gottisch J, Quigley H, Javitt J & Sommer A (1996) The cause-specific prevalence of visual impairment in an urban population, The Baltimore Eye Survey. Ophthalmology 103: 1721-1726.

Raitama KK (1988) Mammografisen rintasyöpäseulonnan vaikuttavuus, kustannukset ja hyödyt. Pro gradu –tutkielma. Kansanterveystiede, Helsingin yliopisto, valtiotieteellinen tiedekunta.

Rajala U, Keinänen-Kiukaanniemi S, Uusimäki A, Reijula K & Kivelä S-L (1995) Prevalence of diabetes and impaired glucose tolerance in middle-aged Finnish population. Scand J Prim Health Care 13: 222-228

Rajala U, Laakso M, Qiao Q & Keinänen-Kiukaanniemi S (1998) Prevalence of retinopathy in people with diabetes mellitus, impaired glucose tolerance and normal glucose tolerance. Diabetes Care 21: 1664-1669

Redhead J, Hussain A, Gedling P, McGulloch AJ (1993) The effectiveness of a primary-care-based diabetes education service. Diabet Med 10: 672-675

Reenders K, de Nobel E, van den Hoogen HJM & van Weel C (1992) Screening for diabetic retinopathy by general practitioners. Scand J Prim Health Care 4: 241-230.

Reenders K, de Nobel E, van den Hoogen HJM, Rutten GEHM & van Weel C (1993) Diabetes and its long-term complications in general practice: a survey in a well-defined population. Fam Pract 10: 169-172.

Reiby A, Minassian DC, Vafidis G, Joseph J, Farrow S, Wu J, Desai P & Conolly A (1998) Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study. Br Med J 316: 1643-1646.

Report of the World Health Organisation Study Group (1985) Diabetes mellitus. The World Health Organisation Technical Report Series 727.

Retinopathy Working Party (1991) A protocol for screening for diabetic retinopathy in Europe. Diabet Med 8: 263-267.

Reunanen A (1990) Diabeteksen esiintyvyys. Duodecim 106: 653-661.

Reunanen A (1996) Suomalainen diabetes. Suom Lääkäril 51: 1097-1100.

Rissanen P (1996) Effectiveness, costs and cost-effectiveness of hip an knee replacements. Stakes, Research reports 64.

Rissanen P (1997) Terveydenhuollon taloudellinen arviointi, priorisointi ja tasa-arvo; Sosiaalilääk Aikak 34: 2-3.

Robinson R (1993a) Economic evaluation of health care, what does it mean? Br Med J 307: 670-673.

Robinson R (1993b) Economic evaluation of health care, costs and cost-minimisation analysis. Br Med J 307: 726-728.

Robinson R (1993c) Economic evaluation of health care, cost-effectiveness analysis. Br Med J 307: 793-775

Robinson R (1993d) Economic evaluation of health care, cost-utility analysis; Br Med J 307: 859-862

Robinson R (1993e) Economic evaluation of health care, cost-benefit analysis. Br Med J 307: 924-6

Robinson R (1993f) Economic evaluation of health care, the policy context. Br Med J 307: 994-996.

Rohan TE, Frost CD & Wald NJ (1989) Prevention of blindness by screening for diabetic retinopathy: a guantitive assessment. Br Med J 299:1198-1201.

Rosenberg T & Klie F (1996) Current trends in newly registered blindness in Denmark; Acta Ophthalmol Scand 74: 395-398.

Ruben ST (1994) Corneal sensation in insulin dependent and non-insulin dependent diabetics with proliferative retinopathy. Acta Ophthalmol 72: 576-580.

Rubin GS, West SK, Muñoz B, Bandeen-Roche K, Zeger S, Schein O, Fried LP and the SEE Project Team (1997). Invest Ophthalmol Vis Sci 38: 557-68

Rutten G, van Eijk J, Beek M & van der Velden H (1990) The quality of diabetes registration in eight general practices. AllgemeinMedizin 19: 68-72

Saini JS, Mittal S (1996) Graded corneal sensitivity for screening of diabetic retinopathy. Indian J Ophthalmol 44: 19-23.

Salive ME, Guralnik J, Christen W, Glynn RJ, Colsher P & Ostfeld AM (1992) Functional blindness and visual impairment in the older adults from three communities. Ophthalmology 99: 1840-1847

Sander B, Larsen M, Engler C, Lund-Andersen H & Parving H-P (1994) Early changes in diabetic retinopathy: Capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmologica 72: 553-559.

Santerre RE & Neun SP (1996) Health economics: theories, insights, and industry studies. Irwin Book Team, USA.

Savolainen EA & Lee QP (1982) Diabetic retinopathy - Need and demand for photocoagulation and its cost-effectiveness: Evaluation based on services in the United Kingdom. Diabetologia 23: 138-140.

Schraer CD, Adler AL, Mayer AM, Halderson KR & Trimble BA (1997) Diabetes complications and mortality among Alaska natives: 8 years of observation. Diabetes Care 20: 314-320.

Schranz AG & Zarabinska L (1995) Retinopathy in Maltese type 2 diabetic patients. Diabet Med 12: 441-444.

Sculpher MJ, Buxton MJ, Ferguson BA, Humbreys JE, Altman JFB, Spiegelhalter DJ, Kirby AJ, Jacob JS, Bacon H, Dudbridge SB, Stead JW, Feest TG, Cheng H, Franklin SL, Courtney P, Talbot JF, Ahmed R & Dabbbs TR (1991) A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabet Med 8: 644-650.

Sculpher MJ, Buxton MJ, Ferguson BA, Spiegelhalter DJ & Kirby AJ (1992) Screening for diabetic retinopaty: A relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ 1: 39-51.

Sebag J, Tang M, Brown S et al. (1994) Effects on pentoxifylline on choroidal blood flow in nonproliferative diabetic retinopathy. Angiology 45: 429-433.

Selby JV, Ray GT, Zhang D & Colby CJ (1997) Excess costs of medical care for patients with diabetes in managed care population. Diabetes Care 20: 1396.

Seppälä V, Rönnemaa T, Laakso M, Kallio V & Pyörälä K (1989) Aikuisiässä sairastuneiden diabeetikkojen hoitokäytäntö KYKS- ja TYKS-piirissä. Suom Lääkäril 44: 1416-1422

Singer DE, Nathan DM, Fogel HA & Schachat AP (1992) Screening for diabetic retinopathy. Ann Intern Med 116: 660-671.

Sintonen H, Pekurinen M, Jämsen, Linnakko & Vinni K (1987) Terveystaloustiede, WSOY Juva.

Sintonen H & Pekurinen M, Linnakko E (1997). Terveystaloustiede, WSOY, Helsinki

Skarfors ET, Selinius KI & Lithell HO (1991) Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. Br Med J 303: 755-760.

Smeeth L & Iliffe S (1998) Effectiveness of screening older people for impaired vision in community setting: systematic review of evidence from randomised controlled trials. Br Med J 316: 660-663.

Smith GD, Neaton JD, Wentworth D, Stamler R & Stamler J for the MRFIT Research Group (1998) Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. Lancet 351: 934-939.

Songer TJ (1992) The economics of diabetes care. Alberti, DeFronzo, Keen, Zimmet (Eds). International Textbook of Diabetes Mellitus, John Wiley & Sons Ltd.

Sosiaali- ja terveydenhuollon lainsäädäntö (1996) Asetus sosiali- ja terveydenhuollon asiakasmaksuista 733/1992, Lakimiesliiton kustannus.

Sox H, Stern S, Owens D & Abrams HL (1989) Assessment of diagnostic technology in health care; National Academy Press, Washington D.C.

Sprafka JM, Pankow J, McGovern PG & French LR (1993) Mortality among type 2 diabetic individuals and associated risk factors: the three city study. Diabet Med 10: 627-632.

Stolar MW & Endocrine Fellows Study Group (1995) Clinical management of the IDDM patient. Diabetes Care 18: 701-707.

Summanen P (1989) Vitreoretinal surgery in diabetic eye disease. Prognostic indicators and long-term follow-up. Yliopistopaino, Helsinki.

Suomen Diabetesliitto ry:n retinopatiatyöryhmä (1992) Diabeettinen retinopatia: seuranta, hoito ja näkövammautuneen diabeetikon kuntoutus. Suom Lääkäril 47: 2199-2211.

Suomen lääketilasto 1997 (1998) Lääkelaitos ja Kansaneläkelaitos, Helsinki.

Suomen tilastollinen vuosikirja 1994 (1994) Valtion painatuskeskus, Helsinki.

Suzuki Y, Muramatsu T, Taniyama M, Atsumi Y, Kawaguchi R, Higuchi S, Hosokawa K, AsahinaT, Murata C & Matsuoka K (1996); Association of aldehyde dehydrogenase with inheritance of non-insulin-dependent diabetes mellitus. Diabetologia 39: 1115-1118.

Svärdsudd K & Tibblin G (1990) Is quality of life affecting survival. Scand J Prim Health Care, suppl 1: 55-60.

The Swedish Council on Technology Assessment in Health Care (1994) Diabetic retinopathy - The Value of Early Detection. Statens Beredning för Utvärdering.

Szklo M (1990) Selective screening: When should screening be limited to high-risk individuals? J Gen Intern Med 5 (suppl): 47-49.

Taylor R, Lovelock L, Tunbridge WMG, Alberti KGMM, Brackenridge RG, Stephenson P & Young E (1990); Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. Br Med J 301: 1243-1247.

Taylor R & the British Diabetic Association Mobile Retinal Screening Group (1996) Practical community screening for diabetic retinopathy using the mobile retinal camera: Report of a 12 centre study. Diabet Med 13: 946-952.

Teräsvirta M (1986) Prevalence of retinopathy and involutional ocular changes in newly detected adult-onset non-insulin-dependent diabetes. Kuopion yliopiston julkaisuja 8.

Testa MA & Simonson DC (1988); Measuring quality of life in hypertensive patients with diabetes. Postgrad Med J 64 (suppl): 50-58.

Thorell B, Olsson L & Svärsudd K (1994) Implementation of a structured care programme for diabetes mellitus in a defined population in mid-Sweden. Diabet Med 15: 139-144.

Tielsch JM, Javitt JC, Coleman A, Katz J & Sommer A (1995) The prevalence of blindness and visual impairment among nursing home resiudents in Baltimore. N Engl J Med 332:1205-1209.

Torgerson DJ & Spencer A (1996) Marginal costs and benefits. Br Med J 312: 35-36.

Torrance GW (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5: 1-30

Torrance GW, Feeny D (1989) Utilities and quality-adjusted life years. Int J Technol Assess Health Care 5: 559-75.

Trautner C, Icks A, Haastert B, Plum F & Berger M (1997) Incidence of blindness in relation to diabetes, a population-based study. Diabetes Care 20: 1147-1160.

Tubman TRJ, Hallidey HL & Normand C (1990) Cost of surfactant replacement for severe neonatal respiratory distress syndrome: a randomised controlled trial. Br Med J, 301: 842-845.

Tuomilehto J (on behalf of the DERI Mortality Study Group) (1989) The classification of mortality in IDDM: The Deri experience; Prognosis of diabetes in children (Eds) Laron Z, Karp M, Karger Basel 1989, Pediatr Adolesc Endocrinol 18: 179-184.

Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengård JH, Pitkänen M, Aro A, Javela K, Uusitupa M & Pitkäniemi J (1991) Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged populaton of three areas in Finland. Int J Epidemiol 20: 1010-1017.

Tuomilehto J & Lounamaa R (1990) Nuoruusiän diabeteksen ennuste. Duodecim 106: 715-723.

Tuomilehto J, Nissinen A, Kivelä S-L, Pekkanen J, Kaarsalo E, Wolf E, Aro A, Punsar S & Karvonen MJ (1986) Prevalence of diabetes mellitus in elderly men aged 65 to 85 years in eastern and western Finland. Diabetologia 29: 611-615.

Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR & Holman RR for the United Kingdom Prospective Diabetes Study Group (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 3: 823-828.

Udvarheley S, Colditz GA, Rai A & Epstein A (1992) Cost-effectiveness and cost-benefit analysis in the medical literature. -Are the methods being used correctly? Ann Intern Med; 116: 238-244.

UK Prospective Diabetes Study (UKPDS) Group (1998a) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853

UK Prospective Diabetes Study (UKPDS) Group (1998b) Effect on intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-865

Uusitupa M, Groop L, Nissén M, Sala SA & Taskinen M-R (1994) Aikuistyypin diabeteksen hoitosuositus. Suomen Diabetesliitto ry:n julkaisusarja 1.

Valtakunnallinen suunnitelma sosiaali- ja terveydenhuollon järjestämisestä vuosina 1993-1996 (1992) Valtion painatuskeskus, Helsinki

Vaughan P, Gilson L & Mills A (1989) Diabetes in developing countries: its importance for public health. Health Policy and Planning 4: 97-109.

van der Veen EA (1988) Epidemiology of diabetes mellitus and risk factors for end-organ disease. Postgrad Med J 64 (Suppl 3): 5-9.

Vehmanen R (1993) An economic evaluation of two caries preventive methods. Turku. Kirjapaino Cityoffset ky Tampere.

Vertio H (1998) Seulonnat lääketieteellisenä toimintamallina. Impakti 1/98:7-8.

Villalpando MEG, Villalpando CG, Diaz SVM, Mitchell B, Martinez DR, Klein R, Haffner SM, Stern MP (1997) Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas. Diabetes Care 20: 773-77

Wahl PW, Savage PJ, Psaty BM, Orchard TJ, Robbins JA, Tracy RP (1998) Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 352: 1012-1015

Walford S (1991) Primary Care Teams and the treatment of diabetes. Diabet Med 8: 307-308.

Wang F & Javitt JC (1996) Eye care for elderly Americans with diabetes mellitus, Failure to meet current guidelines. Ophthalmology 103:1744-1750.

Wareham NJ, O’Rahilly S (1998) The changing classification and diagnosis od diabetes. Br Med J 317: 359-360

Warner DC, McCandless RR, De Nino LA, Cornell JE, Pugh JA & Marsh GM (1996) Costs of diabetes in Texas. Diabetes Care 19: 1416-1469.

de Weerdt I, Visser AP, Kok GJ, de Weerdt O & van der Veen EA (1991) Diabet Med 8: 338-345.

Weinstein MC (1990) Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care 6: 93-103.

Wikblad KF, Wibell LB & Montin KR (1990); The patient’s experience of diabetes and its treatment: construction of an attitude scale by a semantic differential technique. J Adv Nurs 15: 1083-1091.

Wiklund I, Herlitz J, Bengtson A & Hjalmarson Å (1990) Long-term follow-up of health-related quality of life in patients with suspected acute myocardial infarction when diagnosis was not confirmed. Scand J Prim Health Care 9: 47-52.

Wilson JMG & Jungner G (1968) Principles and practise of screening for disease. WHO, Geneve.

World Health Organisation (1973) The prevention of blindness (Techn. Rep. Ser. No 518). WHO, Geneve.

World Health Organisation (1980) International classification of Impairments Disabilities and handicaps. WHO, Geneve.

World Health Organisation (1985) Diabetes mellitus. Report of a WHO study group (Rech. Rep. Ser. No 727). WHO, Geneve.

Wulsin LR, Jacobson AM & Rand LI (1987) Psychosocial aspects of diabetic retinopathy. Diabetes Care 10: 367-373.

Wulsin LR, Jacobson AM & Rand LI (1991). Psychosocial correlates of mild visual loss. Psychosom Med 53: 109-117.

Wulsin LR, Jacobson AM & Rand LI (1993) Psychosocial adjustment to anvanced proliferative diabetic retinopathy. Diabetes Care 16:1061-1066.

Wändell PE, Brorsson B & Åberg H (1998) Diabetic patients in primary health care - quality of care three years apart. Scand J Prim Health Care 16: 44-49

Yadkin JS, Alberti KGMM, McLarty DG & Swai ABM (1990) Impaired glucose tolerance. Br Med J 301: 397-402.

Yang WY, Liu J & Pan XR (1995) Report from the Second Conference of the National Diabetes Prevention and Control Co-operative Group. Chinese J Endocrinol Metab 11: 187-188.

Yeo KT, Fan R & Yong V (1993) Meeting the challenge of diabetic blindness in 90’s. Singapore Med J 34: 128-130.

Yokoyama H, Okudaira M, Takeike H, Miura J, Saeki A, Uchigata Y & Omori Y (1997) Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 20: 844-847.

Yu T, Mitchell P, Berry G, Li W & Wang JJ (1998) Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 116: 83-89

Zimmet PZ, McCarty DJ & de Courten MP (1997) The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications 11: 60-68